{"data":{"id":"us/10-cfr-35.2063","jurisdiction":"us","citation":"10 CFR 35.2063","heading":"Records of dosages of unsealed byproduct material for medical use.","body":"(a) A licensee shall maintain a record of dosage determinations required by § 35.63 for 3 years.\n(b) The record must contain—\n(1) The radiopharmaceutical;\n(2) The patient's or human research subject's name, or identification number if one has been assigned;\n(3) The prescribed dosage, the determined dosage, or a notation that the total activity is less than 1.1 MBq (30 µCi);\n(4) The date and time of the dosage determination; and\n(5) The name of the individual who determined the dosage.","path":["Title 10—Energy","CHAPTER I—NUCLEAR REGULATORY COMMISSION","PART 35—MEDICAL USE OF BYPRODUCT MATERIAL","Subpart L—Records"],"source_url":"https://www.ecfr.gov/api/versioner/v1/full/2026-08-25/title-10.xml","current_through":"2026-08-25","vintage":"","retrieved_at":"2026-08-27T02:24:09Z","sha256":"8fb71c5a63462ea769a74545d93cd13ae2a7b71690fc90d9c279bab0ae880307","source_id":"us-cfr","stale":true,"prev":"us/10-cfr-35.2061","next":"us/10-cfr-35.2067"},"notice":"GroundRules: Original legal text. Not legal advice."}